BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cytoo Launches 2D+ Solutions at High Content Analysis (HCA), January 08 - 11, 2013


1/2/2013 10:14:44 AM

Grenoble, France, 2nd January 2013 – CYTOO, a life science systems & tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS), will launch the 2D+ Solutions at the High Content Analysis (HCA) Annual Meeting in San Francisco. CYTOO’s 2D+ Solutions open fresh perspectives for cell based assay development in drug discovery.

CYTOO’s 2D+ Cell Culture Platform is based on standard and custom adhesive micropatterns in 96-well plates to guide cell architecture and behavior in culture. By defining the 2D topology of cell adhesion, the 2D+ Cell Culture Platform enables fine control of the spreading and 3D shape of cultured cells in single- or multi-cellular configurations. This approach results in control of cell contractility, cell polarity, organelle positioning, and cell division axis. This technology addresses a major concern with traditional 2D culture, in which cells spread and move in an uncontrolled manner, introducing a considerable but unnoticed variability in cell function.

CYTOO’s Custom Solutions bring expertise, resources and technology to address current bottlenecks in cell based assay development and screening. 2D+ Custom Solutions begin with an in-depth analysis of the customer’s assay, by experienced PhD- level experts of the 2D+ technology.

The 2D+ Custom Solutions process includes: Exploratory solutions to guide customers through the initial exploration of the 2D+ technology; Assay development to select the best ecosystem for the requested cells; Screening to run small and medium screens.

Attendees are invited to visit HCA booth #24 to discuss their application with Pauline Poydenot, Head of Cell Assay Services, and Myles Fennell, Application Development Leader.

For more information, visit www.cytoo.com

About CYTOO S.A.

CYTOO is a distinctive life sciences systems & tools company offering disruptive solutions for cell-based assays and High Content Screening (HCS) that reinforce robustness, sensitivity and powerful quantification. The Company’s 2D+ Cell Culture Platform and Custom Solutions are based on adhesive micropatterns, offering control over the cells' microenvironment, leading to normalized cell morphology and behavior. The technology allows the optimization or resurrection of complex or difficult cell-based assays and enables innovative assay development.

For more information about the complete product portfolio, visit www.cytoo.com

Additional Contacts

CYTOO SA

cloiraud@cytoo.com



Read at BioSpace.com

Cytoo
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES